Recent Updates
Recently added Catalysts
STXS Positive Sentiment Score: 70/100

Stereotaxis to Report Second Quarter 2026 Financial Results on August 11, 2026

Key Takeaway: Stereotaxis, Inc. will release its financial results for the second quarter of 2026 on August 11, 2026. The company will hold a conference call and webcast at 4:30 p.m. ET to discuss these results and any corporate developments. Stereotaxis is recognized for its innovations in surgical robotics for minimally invasive procedures.
Price reaction · baseline $1.5 (2026-07-20 close) · hit pre-market · clean, no other STXS news in the window
day 0 close · peak
-2%

Market Sentiment Analysis

POSITIVE FACTORS

  • Stereotaxis is a leader in surgical robotics.
  • The company is set to report its financial results, indicating ongoing operations.
  • The upcoming conference call shows transparency with investors.

Full Press Release Details

ST. LOUIS, July 21, 2026 (GLOBE NEWSWIRE) --Stereotaxis, Inc.(NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will release financial results for its 2026 second quarter on Tuesday, August 11, 2026 at the close of the U.S. financial markets. The Company will host a conference call and webcast at 4:30 p.m. ET that day to discuss the Company’s results and corporate developments.
What: Stereotaxis second quarter 2026 financial results conference call
When: Tuesday, August 11, 2026, at 4:30 p.m. ET (1:30 p.m. PT)
Dial In Number: To access the live call, dial 800-715-9871 (US and Canada) or 1-646-307-1963 (International) and give the participant pass code 4404741.
Webcast: To access the live and replay webcast, please visit the investor relations section of Stereotaxis’ website athttp://ir.stereotaxis.com/.
Call Replay: A phone replay of the call will be available for one month beginning approximately four hours following the end of the call. To request access for a replay of the conference call, pleaseclick here.
About StereotaxisStereotaxis, Inc.(NYSE: STXS) is a pioneer and global leader in innovative surgical robotics for minimally invasive endovascular intervention. Its mission is the discovery, development and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide unsurpassed patient care with robotic precision and safety, expand access to minimally invasive therapy, and enhance the productivity, connectivity, and intelligence in the operating room. Stereotaxis technology has been used to treat over 150,000 patients across the United States, Europe, Asia, and elsewhere. For more information, please visitwww.stereotaxis.com.

Investor Contacts:David L. FischelChairman and Chief Executive OfficerKimberly PeeryChief Financial Officer

Frequently Asked Questions

When will Stereotaxis report its Q2 2026 financial results?

Stereotaxis will report its Q2 2026 financial results on August 11, 2026.

What time is the conference call for Stereotaxis Q2 results?

The conference call for Stereotaxis Q2 results is scheduled for 4:30 p.m. ET.

What is Stereotaxis known for?

Stereotaxis is known for its innovative surgical robotics for minimally invasive procedures.

How many patients have been treated with Stereotaxis technology?

Stereotaxis technology has been used to treat over 150,000 patients worldwide.

Last updated: Jul 21, 2026